Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
Sarepta Announces Topline Three-Year EMBARK Results: Long-Term ...
Sarepta Therapeutics Global Medical Affairs Fellowship Program by ...
Sarepta will resume gene therapy shipments after FDA review of recent ...
Sarepta Therapeutics to Announce First Quarter 2025 Financial Results ...
Sarepta (SRPT) Stock Surges, Analysts Crown it DMD King Over PFE ...
Sarepta Therapeutics Seeks to Expand Delandistrogene Moxeparvovec ...
Sarepta Therapeutics: Why Is SRPT Stock Crashing?
Sarepta Therapeutics Secures Vital Breathing Space with $700 Million ...
Sarepta отказалась прекратить продажи генной терапии после смерти трех ...
Sarepta Therapeutics Stock Soars on Beleaguered Drugmaker's ...
Sarepta shares tumble on trial failure, weak Elevidys outlook
Sarepta Therapeutics Stock Crashes After-Hours On DMD Trial Failure, Q3 ...
Sarepta Stock (SRPT) Is Worth $0 Amid FDA Fight Over Elevidys, Analyst ...
Sarepta shares slump after third patient death this year | Reuters
News & Press Releases | Sarepta Therapeutics
Sarepta Therapeutics | LinkedIn
Sarepta Therapeutics’ Duchenne therapy crisis has a clear lesson
Sarepta Therapeutics - Timberline Construction
Sarepta Therapeutics yeniden yapılanma planı açıkladı, hisse yükseldi ...
Sarepta scraps a Duchenne drug as gene therapy sales rise | BioPharma Dive
Sarepta Therapeutics (SRPT) Stock Chart and Price History 2026
A logo sign outside of the headquarters of Sarepta Therapeutics, Inc ...
The Sarepta Therapeutics headquarters in Cambridge, Massachusetts ...
User | theeveningleader.com - Sarepta Therapeutics Stock Soars on FDA ...
Sarepta Therapeutics on LinkedIn: #asgct2024
Sarepta to lay off about 500 employees after Duchenne gene therapy ...
Sarepta Therapeutics-Aktie springt zweistellig hoch: Umfangreicher ...
#onesarepta | Sarepta Therapeutics
Corporate Responsibility | Sarepta Therapeutics
Photos: Sarepta Therapeutics medical research facility
Join Us | Careers at Sarepta Therapeutics
Sarepta therapeutics : 7 images, photos et images vectorielles de stock ...
Sarepta Therapeutics on LinkedIn: Tonya and Evan from our TA team had a ...
Sarepta Therapeutics on LinkedIn: #dei
Our Disease Areas | Sarepta Therapeutics
Sarepta Therapeutics | Biopharmaceutical Company for Rare Diseases
#esgct | Sarepta Therapeutics
Sarepta Therapeutics Announces Results from Part 2 of the EMBARK Study ...
Sarepta Seeks Label Expansion, Bigger Market for DMD Gene Therapy ...
Sarepta Headquarters at Jessica Dowie blog
Sarepta finally gets some good news: A patient death wasn’t its DMD ...
Sarepta shares jump as CEO’s planned exit spurs takeover speculation ...
Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial ...
Sarepta Komorní Lhotka
Sarepta Therapeutics Announces FDA Approval of ELEVIDYS
Sarepta Therapeutics on LinkedIn: ICYMI: Visit our Newsroom to read ...
Sarepta faces new scrutiny after 3rd patient death
Sarepta Therapeutics on LinkedIn: Scientist II – Study Director
Om Misjon Sarepta – Misjon Sarepta
Sarepta Therapeutics on LinkedIn: In recognition of World Duchenne ...
Sarepta Patrimoine
Global Locations | Sarepta Therapeutics
Sarepta Therapeutics Announces FDA Approval of ELEVIDYS, the First Gene ...
Sarepta Therapeutics Announces Positive Data from Part B of MOMENTUM, a ...
Sarepta Therapeutics logo in transparent PNG and vectorized SVG formats
Sarepta annonce le dosage du premier patient dans l'essai NAVIGENE pour ...
Sarepta and Catalent Expand Strategic Manufacturing Partnership With ...
Sarepta Shares New Functional Data From SRP-9001 Duchenne Gene Therapy ...
У Sarepta новый начальник | МОСМЕДПРЕПАРАТЫ
Sarepta Therapeutics Announces First Quarter 2025 Financial Results and ...
Sarepta Therapeutics Logo - PNG Logo Vector Brand Downloads (SVG, EPS)
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing ...
Sarepta Therapeutics anuncia a los destinatarios de Route 79, el ...
Sarepta Therapeutics DMD Gene Therapy: Sarepta Defies FDA Request Amid ...
Sarepta Therapeutics - Needham
Sarepta Therapeutics: Arrowhead Pharmaceuticals Expects Near-Term ...
Resume Gene Therapy Shipments as FDA Clears Sarepta
FDA Adds Strongest Warning to Sarepta Gene Therapy Linked to 2 Patient ...
Sarepta Therapeutics | $SRPT Stock | Chances of Approval? - Warrior ...
Sarepta Therapeutics lays off 500 after gene therapy setback - Boston ...
In this photo illustration a Sarepta Therapeutics logo is seen on a ...
Sarepta Therapeutics Announces Third Quarter 2023 Financial Results and ...
FDA adds strongest warning to Sarepta gene therapy
Sarepta tanks after death of second teen taking its gene therapy ...
Biotech's Biggest Gainers | Sarepta Therapeutics (SRPT) | StemCells ...
Sarepta Definition at Teresa Huffman blog
Contact Us | Sarepta Therapeutics
Sarepta eyes Elevidys sales comeback with positive Phase III data
Sarepta plunges 40% after-hours as muscle disease drugs fail ...
Sarepta Rockets And Breaks Out As FDA Smooths The Path…
Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2022 ...
FDA clears way for Sarepta Therapeutics to use Duchenne drug in some ...
24 Sarepta Therapeutics Stock Photos, High-Res Pictures, and Images ...
Sarepta Therapeutics (SRPT): Wells Fargo Raises Price Target to
Sarepta reports strong 3rd-qtr 2024 sales growth | Pharmaceutical | The ...
Sarepta Secures FDA Nod For Elevidys Study To Reduce Liver Injury Risk ...
Sarepta Therapeutics Announces Clinical Hold on Micro-Dystrophin Gene ...
Sarepta Announces Update on ENVISION Study Enrollment in U.S. - Parent ...
Sarepta Therapeutics Faces Mounting Challenges as Regulatory and ...
Sarepta Sells Biotech Stake to Raise Cash as Elevidys Troubles Hit Home ...
Sarepta Therapeutics Cuts 500 Jobs Amid Gene Therapy Setbacks and ...
Sarepta Duchenne Gene Therapy Wins Broader Use From FDA - Novacore
FDA adds strongest warning to Sarepta gene therapy linked to 2 patient ...
Sarepta Stock Plummets On 'Double Whammy' After Guidance Cut, Critical ...
Why Sarepta Therapeutics Stock Surged Nearly 48% In After-Hours Trading ...
一文了解Sarepta Therapeutics萨雷普塔治疗logo设计含义解读及基因编辑品牌标志设计理念案例-三文品牌
Elevidys(Delandistrogene Moxeparvovec-rokl)用法用量,副作用,注意事项-问药网
Sarepta’s Week Worsens as FDA Fears, Outlook Cut Hit Stock (SRPT ...
🎖 Qué significa Sarepta: 5 datos fascinantes sobre su historia
A Safety Update on ELEVIDYS - Parent Project Muscular Dystrophy
Logo
Sarepta's DMD gene therapy secures accelerated FDA approval
FDA accepts efficacy supplement to expand the Elevidys indication | The ...
Second patient dies after getting Sarepta's Duchenne gene therapy
Sarepta/Roche Suspend les Essais de Thérapie Génique Elevidys en Europe ...
Sarepta: SRPT Stock To $40?
Roche/Sarepta Therapeutics: A Safety Update on ELEVIDYS – Defeat ...
Veeva MedComms | Medical Affairs Content Management | Veeva
Sarepta’s DMD drug Elevidys to carry liver failure warning | The ...